Kringle Pharma, Inc.
Notice Regarding the Setting of Record Date for the Convocation of an Extraordinary General Meeting of Shareholders
Issuance of stock options to employees as part of the 18th grant. Total of 380 units, 100 shares per unit, dilution expected to be 0.45%. Exercise period from June 26, 2028 to June 25, 2036.
Key Figures
- Total stock options: 380 units
- Shares per unit: 100 shares
- Dilution: 0.45%
- Exercise period: 2028-06-26 to 2036-06-25
AI要約
Overview
This today announces the resolution to issue the 18th employee stock option (stock appreciation rights). A total of 380 units, with 100 shares per unit, are subject to rights, including adjustment provisions for stock splits, etc. Dilution is expected to be approximately 0.45% against the total outstanding shares of 8,383,200, with explanations that the impact is limited. Exercise period is from June 26, 2028 to June 25, 2036.
Impact on shareholders and outlook
The stock options are granted free of charge, and detailed terms such as exercise conditions, calculation method of exercise price, and adjustments in case of splits or reverse splits are specified. Aimed at mid- to long-term improvement in employee performance and enhancement of shareholder value, cash outflows are not incurred, and dilution is limited. In the long term, improvements in talent motivation and organizational performance are expected.
Kukuringuru Pharmacy Co., Ltd.
Company overview · Stock price · Financial data · All IR
